CA1045628A - Labile quaternary ammonium salts as transient derivatives - Google Patents

Labile quaternary ammonium salts as transient derivatives

Info

Publication number
CA1045628A
CA1045628A CA229,912A CA229912A CA1045628A CA 1045628 A CA1045628 A CA 1045628A CA 229912 A CA229912 A CA 229912A CA 1045628 A CA1045628 A CA 1045628A
Authority
CA
Canada
Prior art keywords
group
chloride
methyl
hydrogen atom
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA229,912A
Other languages
English (en)
French (fr)
Other versions
CA229912S (en
Inventor
Nicolae S. Bodor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Interx Research Corp
Original Assignee
Interx Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interx Research Corp filed Critical Interx Research Corp
Application granted granted Critical
Publication of CA1045628A publication Critical patent/CA1045628A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA229,912A 1974-06-24 1975-06-23 Labile quaternary ammonium salts as transient derivatives Expired CA1045628A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/482,513 US3998815A (en) 1974-06-24 1974-06-24 1-hydrocarbonoyloxymethyl-3-carbamoyl or 3-carboethoxy-pyridinium salts

Publications (1)

Publication Number Publication Date
CA1045628A true CA1045628A (en) 1979-01-02

Family

ID=23916371

Family Applications (1)

Application Number Title Priority Date Filing Date
CA229,912A Expired CA1045628A (en) 1974-06-24 1975-06-23 Labile quaternary ammonium salts as transient derivatives

Country Status (6)

Country Link
US (2) US3998815A (enExample)
AU (1) AU8241275A (enExample)
CA (1) CA1045628A (enExample)
DE (1) DE2527993A1 (enExample)
FR (1) FR2276289A1 (enExample)
GB (1) GB1471828A (enExample)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3998815A (en) * 1974-06-24 1976-12-21 Interx Research Corporation 1-hydrocarbonoyloxymethyl-3-carbamoyl or 3-carboethoxy-pyridinium salts
US4171452A (en) * 1975-11-14 1979-10-16 Interx Research Corporation Antibacterially active N-chloroamino ester derivatives of alkyl carboxylates
JPS52122316A (en) * 1976-04-07 1977-10-14 Interx Research Corp New transitional quarternary ammonium salt compound
DK534178A (da) * 1977-12-16 1979-06-17 Interx Research Corp Anticholinerge midler med sektrtionshaemmende virkning
DE2914721A1 (de) * 1978-04-17 1979-10-18 Kyowa Hakko Kogyo Kk Verfahren zur bestimmung der cholinesterase-aktivitaet sowie fuer dieses verfahren verwendbare cholin-derivate
JPS5935599B2 (ja) * 1980-12-25 1984-08-29 株式会社 シノテスト研究所 コリンエステラ−ゼ活性測定法
HU186656B (en) * 1982-12-28 1985-09-30 Richter Gedeon Vegyeszet Process for producing new benzhydryl-piperazine derivatives, acid additionak salts and pharmaceutical compositions containing them
EP0195016A1 (en) * 1984-08-23 1986-09-24 Sandoz Ag Cyclimmonium salts
DE3443678A1 (de) * 1984-11-30 1986-06-05 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 4-acyloxy-3-oxo-buttersaeureestern
US5223528A (en) * 1986-03-17 1993-06-29 University Of Florida Anticholinergic compounds, composititons and methods of treatment
IE60645B1 (en) * 1986-03-17 1994-08-10 Univ Florida Anticholinergic compounds, pharmaceutical compositions and method of treatment
US5258388A (en) * 1986-03-17 1993-11-02 University Of Florida Anticholinergic compounds, compositions and methods of treatment
US5886162A (en) * 1989-11-03 1999-03-23 Research Foundation Of State University Of New York Lipophilic diakylaminomethylene prodrug derivatives for the inhibition of replication of viruses
US6573282B1 (en) 1995-09-12 2003-06-03 Adolor Corporation Peripherally active anti-hyperalgesic opiates
US5849761A (en) * 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
WO1997044022A1 (en) * 1996-05-20 1997-11-27 G.D. Searle & Co. Potassium, sodium and tris oxaprozin salt pharmaceutical formulations
RU2189982C2 (ru) 1997-03-31 2002-09-27 Такеда Кемикал Индастриз, Лтд. Азольные соединения, способ их получения, противогрибковая фармацевтическая композиция и способ лечения грибковой инфекции
ATE261730T1 (de) * 1997-12-31 2004-04-15 Univ Kansas Wasserlösliche medikamentenvorstufen tertiärer amine enthaltender medikamente und verfahren zu ihrer herstellung
IE20070597A1 (en) * 2007-08-21 2009-04-01 Univ Dublin City Biodegradable solvents for the chemical industry: task specific ionic liquids
ES2639065T5 (es) * 2009-06-25 2023-01-30 Alkermes Pharma Ireland Ltd Compuestos heterocíclicos para el tratamiento de trastornos neurológicos y psicológicos
AU2010266040B2 (en) 2009-06-25 2015-01-15 Alkermes Pharma Ireland Limited Prodrugs of NH-acidic compounds
EP2521711B1 (en) * 2010-01-07 2017-08-16 Alkermes Pharma Ireland Limited Quaternary ammonium salt prodrugs
EP2585066B1 (en) 2010-06-24 2018-09-26 Alkermes Pharma Ireland Limited Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
PL2685979T3 (pl) 2011-03-18 2017-02-28 Alkermes Pharma Ireland Limited Kompozycje farmaceutyczne do wstrzykiwania zawierające środek nierozpuszczalny w wodzie, środek przeciwpsychotyczny, laurynian sorbitanu i polisorbat 20
WO2013088255A1 (en) 2011-12-15 2013-06-20 Alkermes Pharma Ireland Limited Prodrugs of secondary amine compounds
CA2867137C (en) 2012-03-19 2020-12-08 Alkermes Pharma Ireland Limited Pharmaceutical compositions comprising aripiprazole prodrugs and benzyl alcohol
US9993556B2 (en) 2012-03-19 2018-06-12 Alkermes Pharma Ireland Limited Pharmaceutical compositions comprising fatty glycerol esters
AU2013235519C1 (en) 2012-03-19 2018-04-26 Alkermes Pharma Ireland Limited Pharmaaceutical compositions comprising fatty acid esters
NZ730571A (en) 2012-09-19 2018-12-21 Alkermes Pharma Ireland Ltd Pharmaceutical compositions having improved storage stability
AU2013326850B2 (en) 2012-10-04 2017-09-21 Inhibikase Therapeutics, Inc. Novel compounds, their preparation and their uses
WO2014054058A2 (en) * 2012-10-05 2014-04-10 Sphaera Pharma Pvt. Ltd. Novel compounds, their synthesis and their uses
BR112016021535A8 (pt) 2014-03-20 2021-07-20 Alkermes Pharma Ireland Ltd kit compreendendo formulações de aripiprazol tendo velocidades de injeção aumentadas útil para o tratamento de uma desordem do sistema nervoso central e uso
CN105315170B (zh) * 2014-08-01 2017-08-25 四川大学华西医院 二甲基苯铵类长链化合物、制备、自组装结构及用途
CN110092731B (zh) * 2018-01-31 2022-03-04 四川大学华西医院 长链胺取代的二甲基苯铵类化合物、制备、自组装结构及用途
AU2019230014B2 (en) 2018-03-05 2024-11-28 Alkermes Pharma Ireland Limited Aripiprazole dosing strategy
WO2021087113A1 (en) 2019-10-30 2021-05-06 Children's Medical Center Corporation Local anesthetics with selective-sensory nerve blockade
CN113396139A (zh) * 2020-01-13 2021-09-14 易天奇 基于苯环超分子相互作用的芳基酰胺类化合物、自组装形态及用途
CN115215759B (zh) * 2021-04-19 2023-10-20 四川大学华西医院 一种兼具长效局部麻醉和选择性局部麻醉作用的酰胺类季铵盐衍生物
CN115536641B (zh) * 2022-09-29 2024-12-27 广州润尔眼科生物科技有限公司 一种内酯化合物及其制备方法与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3396127A (en) * 1964-05-22 1968-08-06 Eastman Kodak Co Photographic hardeners
US3998815A (en) * 1974-06-24 1976-12-21 Interx Research Corporation 1-hydrocarbonoyloxymethyl-3-carbamoyl or 3-carboethoxy-pyridinium salts
US3989711A (en) * 1975-09-22 1976-11-02 Interx Research Corporation Soft quaternary surface active agents exhibiting antibacterial activity

Also Published As

Publication number Publication date
US4160099A (en) 1979-07-03
DE2527993C2 (enExample) 1988-08-11
FR2276289B1 (enExample) 1979-10-19
FR2276289A1 (fr) 1976-01-23
DE2527993A1 (de) 1976-01-15
GB1471828A (en) 1977-04-27
AU8241275A (en) 1977-01-06
US3998815A (en) 1976-12-21

Similar Documents

Publication Publication Date Title
CA1045628A (en) Labile quaternary ammonium salts as transient derivatives
US4723011A (en) Preparation of substituted and disubstituted-pyridine-2,3-dicarboxylate esters
JPS58501723A (ja) シアノヘテロ環化合物の製法
Packiaraj et al. Preparation, thermal behavior, luminescent properties, and crystal structures of aminoguanidinium 2, n-pyridine-dicarboxylate (n= 3, 4, 5, and 6) salts
CS183391A3 (en) Process for preparing dialkylpyridine-2,3-dicarboxylates and derivatives thereof
SE452610B (sv) Sett att spalta racemiska cis-1,2-cyklopropandikarboxylsyraderivat
BRPI0721386B1 (pt) processo para preparação de 2-substituídas -5-(1-alquiltio)-alquil piridinas, e intermediário
JPS63270678A (ja) 新規含窒素化合物
WO1983003096A1 (fr) Derives d'immidazole
JPS5924145B2 (ja) 1−メチル−3,5−ジフエニルピラゾ−ルの製法
JPS6223742B2 (enExample)
US4414217A (en) 3,5-Di(t-butyl)-4-hydroxyphenyl substituted pyridines
YAMANAKA et al. Studies on pyrimidine derivatives. V. Reaction of 2, 4-dimethylazines with ethyl benzoate under basic conditions
JPS5813583A (ja) 2−(2−チエニル)−および−(3−チエニル)エチルアミン誘導体の製造方法
JPS58148860A (ja) ピリジン誘導体、その製法および用途
Messmer et al. Direct arylation of tetrazolo [1, 5-a] pyridine and its benzenologues
SMITH et al. Convenient Syntheses of 1, 2, 3, 4-Tetrahydroquinoxalines
JP2845553B2 (ja) ニトロチオフェン化合物
US2030373A (en) Derivatives of thiazole and process of preparing the same
Sammes et al. Synthetic applications of N–N linked heterocycles. Part 16. Reactions between carbanions derived from carbon acids with p K a 7–14 and N-(2, 6-dimethyl-4-oxopyridin-1-yl) pyridinium tetrafluoroborate: synthesis of 4-substituted pyridines, and observation of pyridine ringopening reactions
JPH03215488A (ja) ピリミドベンズイミダゾール誘導体
Apen et al. Metallation and reaction of 4, 5‐dicyanoimidazoles with alkyllithium reagents
US3300506A (en) 1-indolyl substituted-2-pyridyl-ethanes
Castineiras et al. Synthesis, spectroscopic characterization and X-ray crystal structure of 2-(4-methylpyridinium)-5-(4-pyridinium)-1, 3-dithiolane-2, 4-dicarboxylic acid dithiocyanate monohydrate
JPS59190967A (ja) 1−(2,6−ジフルオロフエニル)−2−インドリノン誘導体